鉴定骨髓衍生抑制细胞和利波卡林-2作为脊椎间盘退化治疗点

Changmeng Zhang1, Haoyun Li2, Hongfei Wang1

  • 1Department of Orthopaedics and Traumatology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong.

概括

早期的椎间盘退化 (IVDD) 涉及到表达LCN2的保护性骨髓衍生抑制细胞 (MDSCs). 先进的IVDD显示炎症巨细胞增加,LCN2可能作为IVDD的治疗剂.